Thierry Judge, a master’s student in the Department of Computer Science at the University of Sherbrooke, has developed a technology that identifies when results generated by emerging artificial intelligence (AI) systems — which speed up analysis of ultrasound images to detect heart disease — are incorrect or uncertain. The software, called CRISP, is currently being tested by Oxford, UK-based, Ultromics Ltd, a leader in AI echocardiography. 

A lack of innovation in prosthetics in recent decades means opportunity for Halifax start-up Awenza Health Inc. Founded two years ago, the company is working to disrupt the prosthetics market and provide better solutions for patients through new technologies. 

The need 

Many current products on the market, says CEO Sam Awara, cause high levels of discomfort and even pain in some situations. So Awenza is building a suite of products to solve these issues for those with limb differences. 

While Juliette Champeil pursues her PhD in Chemical Engineering at Laval University, she also serves as co-founder and CEO of her bioengineering start-up, Ivano Bioscience. The company is advancing Champeil’s breakthrough innovation: ready-to-use lab test kits that come pre-loaded with bioengineered artificial cells and viruses designed to mimic real life. The test kits speed up the process for testing new vaccines, helping them get to market faster. 

Speedy solution 

Injuries and bad habits can derail an athlete’s career and quality of life. Pascal McCarthy learned this first-hand when his professional volleyball career was cut short due to recurring injuries. That’s when he saw the gaps in the medical system when it comes to treating sports injuries, including concussions, and decided to do something about it. 

Karina Gasbarrino uses AI to tackle the second-leading cause of death and third-leading cause of disability worldwide – stroke. Her journey started more than a decade ago when she lost her grandfather to a sudden stroke. Since then, she has devoted her academic career to his memory, helping to advance early detection and diagnosis of harmful fatty deposits in the arteries of the neck. Rupturing of these plaques is the main cause of strokes. 

It’s difficult, dirty and dangerous work, but someone has to do it. For clients of Copperstone Technologies, that someone is an amphibious robot. 

The Internet is the decisive technology of the Information Age. This global network of computer systems, largely based on platforms of wireless and near instant communication, provides limitless opportunities for multimodal interaction in chosen time, transcending space. Increasingly driven by the need to constantly produce greater amounts of information and knowledge, the Internet transmits data at higher and higher speeds over fibre optic networks and its impact on culture and commerce has fundamentally altered the way we live, work, and interact. 

The COVID-19 pandemic sparked an urgent need for innovation in all aspects of our lives – and researchers rose to the challenge. From COVID-19 diagnostics and treatments to changes in how we work and receive healthcare, the pandemic has fast-tracked innovation across sectors. 

High-potential researchers and businesses around the world did a pandemic pivot, shifting their work and resources to respond to the world’s pressing need for solutions. In Canada, Seyyedarash (Arash) Haddadi’s story is a standout example of innovation partnerships helping to counter the COVID-19 threat. 

Former Mitacs postdoctoral researcher Dr. Ulrich Legrand understands that the world is facing major challenges due to climate change. He also knows that decision-makers are looking for solutions to the global crisis while driving economic growth

“Governments and businesses agree that reducing emissions is the right thing to do to protect the environment, but at the same time, they want to see a financial benefit,” Dr. Legrand says. And he has developed a first-of-its-kind technology that does just that.

When 31-year-old Jason Deglint was completing his PhD in systems design engineering at University of Waterloo, he decided to tackle a problem that costs an estimated $2 billion in damages and losses in the aquaculture industry: the harmful algae blooms that kill fish.

Deglint dedicated his thesis research to developing a smart, low-cost prototype imaging system to analyze samples in the lab. With support from the Mitacs Accelerate Entrepreneur program, his efforts resulted in the creation of Blue Lion Labs, a new small business based in Waterloo, Ontario.